.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The CALORIES trial compared early enteral with early parenteral nutritional support in adults admitted unexpectedly to the ICU. Nutritional support began within 36 hours and was continued for up to five days, providing a pragmatic test of an everyday ICU decision. The trial did not demonstrate the expected survival advantage of early parenteral nutrition over enteral nutrition. Importantly, the study helped clarify that the route of feeding alone does not determine outcome; timing, dose, tolerance and the patient's underlying illness also matter. For HCPs, the paper supports a practical approach to nutrition: establish an individualised plan, favour the enteral route when feasible, monitor tolerance and avoid assuming that more aggressive feeding is automatically better. CritiCARE's nutrition sessions highlight protein delivery, feeding during shock, micronutrients and metabolic monitoring. CALORIES is a useful foundation for that discussion because it demonstrates why route, timing and energy delivery should be considered separately. The broader lesson is that ICU nutrition should be treated as active clinical management rather than a background supportive task. It needs regular reassessment as haemodynamics, gastrointestinal function, renal replacement and organ support evolve.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The CALORIES trial compared early enteral with early parenteral nutritional support in adults admitted unexpectedly to the ICU. Nutritional support began within 36 hours and was continued for up to five days, providing a pragmatic test of an everyday ICU decision. The trial did not demonstrate the expected survival advantage of early parenteral nutrition over enteral nutrition. Importantly, the study helped clarify that the route of feeding alone does not determine outcome; timing, dose, tolerance and the patient's underlying illness also matter. For HCPs, the paper supports a practical approach to nutrition: establish an individualised plan, favour the enteral route when feasible, monitor tolerance and avoid assuming that more aggressive feeding is automatically better. CritiCARE's nutrition sessions highlight protein delivery, feeding during shock, micronutrients and metabolic monitoring. CALORIES is a useful foundation for that discussion because it demonstrates why route, timing and energy delivery should be considered separately. The broader lesson is that ICU nutrition should be treated as active clinical management rather than a background supportive task. It needs regular reassessment as haemodynamics, gastrointestinal function, renal replacement and organ support evolve.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
